Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...

Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.

GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, at a cash price of $499 per month.

GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...

People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...

The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...

FAIRMONT — CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found it violated state code. The $1.4 million fine is based on ...

Wegovy maker Novo Nordisk warns of layoffs as competition grows Sales slumped especially in the US market as Wegovy’s grip on the obesity drug market loosens ...

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in ...

CalPERS partners with CVS Caremark to manage pharmacy benefits, a deal expected to save $600M over 5 years and tackle rising drug costs for state workers.

Novo Nordisk lowers 2025 guidance as Wegovy and Ozempic face slower U.S. uptake, competition, and continued compounded GLP-1 sales.

Torrent Pharmaceuticals Ltd aims to be in the first wave of generic launches of Novo Nordisk's weight-loss drugs Wegovy and Ozempic in Brazil starting next year, the company’s management said on ...